Course Name
7th PCPM - Ateneo CCE Diploma in Pharmaceutical Medicine & Management
Schedule
September 17, 2024 - March 01, 2025
Tuesdays – Wednesdays, 5:30 – 7:30 pm
Saturdays, 8:30 am – 12:30 pm
Click here for the schedule breakdown
Early Eagle Rate:
Php 76,500
Valid Until:
September 03, 2024
Description
Pharmaceutical Medicine is the medical scientific discipline concerned with the discovery, development, evaluation, registration, monitoring and medical aspects of the marketing of medicines for the benefit of patients and the health of the community.
In terms of governance, pharmaceutical physicians/ medical & regulatory personnel are accountable for the naturegality and standards, including ethical standards, of their work to their employers, to their professional bodies, and under the law as administered by the national Drug Regulatory Authority.
The Ateneo-PCPM Diploma in Pharmaceutical Medicine and Management consists of seven modules that aim to provide the technical knowledge and skills that will equip the pharmaceutical physicians/ medical and regulatory personnel with a core set of competencies aligned with international standards for the appreciation and/or practice of pharmaceutical medicine, at same time in line with Ateneo’s thrust on nation-building.
Course Requirements:
This online program, conducted via Zoom Platform and the AteneoBlueCloud (Learning Management System) consists of:
- A pre-session for orientation and pre-program assessment;
- The program itself, delivered through lectures, written examinations, group presentations and small & large-group discussions; and
- Post-program assessment and examination.
Who should attend
Medical doctors, allied health professionals, and management executives who want to gain competencies in the disciplines involving discovery, development, evaluation, monitoring and medical aspects in marketing of medicines for the benefit of patients and public.
Assessment of the Participants:
This program is consists of a series of specialized courses designed in consultation with specialists and experts on Pharmaceutical Medicine and Management in the country.
The description, coverage, content, program requirements, teaching/learning delivery systems, target facilitators, monitoring and evaluation scheme for the program are jointly formulated by ATENEO and PCPM Consortium Committee.
The participants are graded based on attendance, class participation, assignments, examinations and/or individual or group presentations. Grading shall be made according to the Ateneo Quality Point Index (QPI) system.
A participant who successfully completed and passed all seven (7) modules of the program will receive a diploma and grade certificate. He/she may also earn MBA elective credits from the Ateneo Graduate School of Business (AGSB) depending on the program they choose to pursue.
After the course, you will develop the competencies of the International Federation of Associations of Pharmaceutical Physicians (IFAPP):
- Understand and apply medical science principles and statistics in the evaluation, development, and discovery of new medicines within the context of regulatory environments;
- Design, execute clinical trials and prepare manuscripts or reports for publication and regulatory submissions;
- Interpret effectively the regulatory requirements for the clinical development of a new drug, product life cycle, to ensure its appropriate therapeutic use and proper risk management;
- Evaluate the choice, application, and analysis of post-authorization surveillance methods to meet national/international agency requirements for proper information and risk minimization to patients and clinical trial subjects;
- Combine the principles of clinical research and business ethics for the conduct of clinical trials and commercial operations;
- Appraise the pharmaceutical business activities in the healthcare environment to ensure they remain appropriate, ethical, and legal to keep the welfare of patients and subjects in the promotion of medicines and design of clinical trials; and
- Able to apply the principles and practice of people management and leadership, effective communication, and interpersonal skills to influence key stakeholders and achieve scientific and business objectives.
I. Discovery of Medicines and Early Development
A. Therapeutics in pharmacology
B. Discovery of new medicines
C. Planning and organization
D. Regulation and ethics
E. Pre-clinical drug development
F. Exploratory clinical development
G. Clinical Pharmacokinetics
II. Clinical Development and Clinical Trials
A. Clinical trial planning and management
B. Clinical trial designs, conduct, and documentation
C. Trial design, hypothesis testing, power
D. Measurement and types of data
E. Data collection and management
F. Types of analysis
G. Interpretation of study design, analysis and results
III. Medicine Regulation
A. Legal and medicines regulation
B. Good practices, harmonization, CTD, labels, AR reports, drug abuse-dependence
C. Clinical trials, ethics, drug classification
IV. Drug Safety Surveillance
A. Drug safety regulation
B. Drug safety in preclinical phase
C. Drug safety in clinical trials
D. Pharmacovigilance
E. Pharmacoepidemiology
V. Ethics and Subject Protection
A. Business Ethics
B. ICH Guidelines
C. Historical Abuses and Vulnerability
D. Culture, Ethical and Professional Issues
VI. Healthcare Marketplace
A. Philippine Healthcare Financing
B. Healthcare Delivery System
C. Epidemiologic Shift
D. Basic Principles of Marketing and the Role of Medical Department
VII. Communication and Management
A. Organizational Culture
B. Principles of Change Management
C. Basics of Communication
D. Social Media
E. Ethics, Media and PR
F. Crisis Communications
Dr. Jonas D. Policarpio is currently the Medical Director of Unilab Consumer Health, and is a member of the Healthcare Council of Gerson Lehrman Group (GLG) Research. Alongside his corporate positions, he holds several academic appointments as Professorial Lecturer of Health Economics and Management at the UERM Memorial Medical Center Graduate School.
He is the Program Director of the Ateneo CCE – Philippine College of Pharmaceutical Medicine Diploma Course on Pharmaceutical Medicine and Management, and a member faculty of the Ateneo Graduate School of Business MBA-Health Program. He is also a visiting lecturer of the Departments of Pharmacology of UERM College of Medicine and the St. Luke’s Medical Center College of Medicine. Dr. Policarpio has accumulated over 25 years of corporate and business consulting experience in several companies namely: Medical Project Manager: Servier/MedAsia, Vice President for Business Development: Dharmala Group Healthcare, Managing Director: The Healthcare Business Consulting Group, Medical Director: Ritemed Philippines Inc., and Medical Director: United Laboratories Consumer Health.
Dr. Policarpio holds several academic degrees: B.S. Psychology from the UST College of Science, Doctor of Medicine from UERM College of Medicine, Master of Business Administration from the UP Cesar Virata School of Business. He also took masters studies in Health and Population Economics from the UP School of Economics, the Pharmaceutical Marketing Management Course in ORS-Courbevoie Paris, France, Occupational Medicine Diplomate Course and Pharmaceutical Medicine and Management from the Ateneo CCE. Dr. Policarpio is a member of the Philippine Society of Experimental and Clinical Pharmacology, Philippine College of Occupational
Medicine, and was the former president of the Philippine College of Pharmaceutical Medicine (PCPM).
